Soft-line biotech identity for Onco-Vira.
A self-contained demo with the logo embedded directly in the page, using the same pale-blue linework, rounded frame language, and quiet premium style from the Onco-Vira mark.
Onco-vira is an AI-native mRNA vaccine design platform mapping shared viral tumour antigens to Asian HLA populations.
From viral antigen maps to manufacturable mRNA-LNP vaccine candidates.
OV-101 is an off-the-shelf HBV-shared-antigen mRNA vaccine candidate for adjuvant treatment of HBV-related hepatocellular carcinoma.
OV-101A is recommended as the lead construct due to strong HBx conservation across HBV genotype B/C.
Workflow
From data map to candidate recommendation, expressed as a simple product flow.
Data Engine
Unifies viral maps, tumour signals, and program evidence.
Reusable foundation for future assets.Antigen Discovery
Ranks shared viral tumour targets and narrows the shortlist.
Focuses resources on stronger opportunities.HLA Optimiser
Weights candidates around Asian population fit.
Sharpens the Asia-first thesis.Construct Studio
Compares lead and backup construct concepts.
Turns target logic into product logic.LNP Intelligence
Adds manufacturability and delivery readiness.
Connects design to translation.Learning Loop
Feeds program learnings back into future cycles.
Builds a compounding data moat.Platform modules
Cleaner and less academic, with enough detail to make the platform credible to investors.
Data Engine
The system of record for viral oncology programs.
- Aggregates core datasets
- Standardises evidence
- Supports repeatable setup
Antigen Discovery Engine
Finds the strongest target combinations.
- Ranks candidates
- Builds shortlists
- Makes decisions traceable
HLA Optimiser
Turns biology into population fit.
- Asian HLA weighting
- Market-specific fit
- Clearer program thesis
Construct Studio
Compares lead and backup product concepts.
- Lead selection
- Backup strategy
- Candidate clarity
LNP Intelligence
Adds manufacturability thinking earlier.
- Delivery fit
- Readiness flags
- CMC narrative
Clinical Learning Loop
Makes each program strengthen the next.
- Feedback capture
- Model improvement
- Data moat
HBV-HCC Antigen-to-Construct Workflow
Investor-facing product cockpit for lead candidate recommendation.
Lead candidate recommendation, backup path, and platform-fit view.
One lead asset proves the engine; follow-on programs create the platform story.
Investor readout
The UI is now driven by the logo itself: pale blue outline, large capsule frames, and quieter product storytelling.
It no longer reads like the previous reference site.
Reduced visual noise and softer blue hierarchy.
The demo feels like a proprietary platform cockpit.
Lead asset plus repeatable engine is clearer.